COVID-19 Vaccination: Considerations for Public Health and Policy

Dear Colleagues,

Development and large-scale implementation of COVID-19 vaccination represent a promising tool for reaching herd immunity and ending this global crisis. Nevertheless, many questions ought to be answered regarding current approaches to vaccination in order to build an effective and equitable public health response to the current crisis as well as build preparedness for future pandemics.

This issue addresses all the pertinent public health aspects of COVID-19 vaccination, with an overarching goal to further advance the current evidence base, support decision-making and inform changes in policies at local, regional and global levels. We welcome multidisciplinary work, including submissions from behavioural scientists, psychologists, epidemiologist, data analytics experts, public health specialist etc.

In this Special Issue, original research articles and different types of evidence-summaries are welcome.  Research areas may include (but not limited to) the following:

1. COVID-19 vaccine acceptance, hesitancy, and refusal, including assessments of the evolving epidemiology and understating of individual, group –level and context-specific determinants of these phenomena.
2. Monitoring and continued development of COVID-19 vaccines, including efficacy and effectiveness of vaccines in the context of emerging variants, safety, booster doses, mixing and matching vaccines.
3. Public health and policy issues, including vaccine deployment, ensuring equitable access, communication strategies for encouraging vaccine uptake and introduction of vaccine passports.

We look forward to receiving your contributions. Drs. Stojanovic and Lavoie

Dr. Jovana Stojanovic
Prof. Dr. Kim L. Lavoie
Prof. Dr. Simon Bacon
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.